PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,000 | 0.0% | 739 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,000 | 0.0% | 739 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $2,000 | 0.0% | 739 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $2,000 | 0.0% | 739 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $2,000 | 0.0% | 739 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $2,000 | -33.3% | 739 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $3,000 | -25.0% | 739 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $4,000 | -20.0% | 739 | 0.0% | 0.00% | -25.0% |
| Q2 2015 | $5,000 | 0.0% | 739 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $5,000 | -16.7% | 739 | 0.0% | 0.00% | -20.0% |
| Q4 2014 | $6,000 | +200.0% | 739 | +123.9% | 0.01% | +150.0% |
| Q3 2014 | $2,000 | +100.0% | 330 | +94.1% | 0.00% | +100.0% |
| Q3 2013 | $1,000 | 0.0% | 170 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $1,000 | – | 170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |